{
  "ticker": "ACAD",
  "company_name": "ACADIA Pharmaceuticals",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02970305",
      "title": "Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Schizophrenia",
      "start_date": "2016-11-04",
      "completion_date": "2019-10-28",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT04531982",
      "title": "Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Schizophrenia",
      "start_date": "2020-08-05",
      "completion_date": "2024-02-19",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT00628420",
      "title": "Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Schizophrenia",
      "start_date": "2005-01",
      "completion_date": "2007-10",
      "enrollment": 0,
      "sponsor": "University of Texas Southwestern Medical Center"
    },
    {
      "nct_id": "NCT02970292",
      "title": "Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1)",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Schizophrenia",
      "start_date": "2016-10-26",
      "completion_date": "2019-06-25",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT03947216",
      "title": "Randomized Placebo Controlled Trial Evaluating the Efficacy of Pimavanserin, a Selective Serotonin 5-HydroxyTryptamine-2A (5HT2A) Inverse Agonist, to Treat Impulse Control Disorders in Parkinson's Disease.",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Parkinson Disease",
      "start_date": "2020-10-23",
      "completion_date": "2024-06-17",
      "enrollment": 0,
      "sponsor": "University Hospital, Strasbourg, France"
    },
    {
      "nct_id": "NCT00361166",
      "title": "Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Schizophrenia",
      "start_date": "2005-08",
      "completion_date": "2007-03",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT06159673",
      "title": "ACP-204 in Adults With Alzheimer's Disease Psychosis",
      "status": "RECRUITING",
      "phase": "PHASE2, PHASE3",
      "condition": "Alzheimer's Disease Psychosis",
      "start_date": "2023-11-14",
      "completion_date": "2028-02",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT04164758",
      "title": "Study to Evaluate Safety and Daytime Sedation in Subjects With Parkinson's Disease With Neuropsychiatric Symptoms Treated With Pimavanserin or Low-Dose Quetiapine",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Parkinson's Disease",
      "start_date": "2019-10-23",
      "completion_date": "2020-09-25",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    },
    {
      "nct_id": "NCT05796167",
      "title": "Pimavanserin for Sleep in Parkinson Disease",
      "status": "WITHDRAWN",
      "phase": "EARLY_PHASE1",
      "condition": "Parkinson Disease",
      "start_date": "2023-01-27",
      "completion_date": "2024-06-24",
      "enrollment": 0,
      "sponsor": "State University of New York - Downstate Medical Center"
    },
    {
      "nct_id": "NCT01174004",
      "title": "A Study of the Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "Parkinson's Disease Psychosis",
      "start_date": "2010-07",
      "completion_date": "2012-11",
      "enrollment": 0,
      "sponsor": "ACADIA Pharmaceuticals Inc."
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE2": 19,
      "PHASE3": 19,
      "PHASE1": 1,
      "PHASE2, PHASE3": 4,
      "EARLY_PHASE1": 1,
      "": 3,
      "PHASE4": 3
    },
    "by_status": {
      "COMPLETED": 27,
      "RECRUITING": 6,
      "TERMINATED": 9,
      "WITHDRAWN": 3,
      "ENROLLING_BY_INVITATION": 3,
      "ACTIVE_NOT_RECRUITING": 1,
      "APPROVED_FOR_MARKETING": 1
    },
    "active_trials": 10,
    "completed_trials": 27,
    "conditions": [
      "Acute Postoperative Pain, Bunionectomy",
      "Adjunctive Treatment of Major Depressive Disorder",
      "Agitation and Aggression in Alzheimer's Disease",
      "Alzheimer's Disease Psychosis",
      "Autism Spectrum Disorder",
      "Dementia-related Psychosis",
      "Hallucinations, Psychoses, Parkinson's Disease",
      "Hyperphagia in Prader-Willi Syndrome",
      "Insomnia Chronic, Posttraumatic Stress Disorder",
      "Intermittent Explosive Disorder",
      "Irritability Associated With Autism Spectrum Disorder",
      "Lewy Body Dementia Psychosis",
      "Major Depressive Disorder (MDD), Depressive Disorder, Treatment-Resistant",
      "Neurodegenerative Diseases, Parkinson Disease, Parkinson Disease Psychosis",
      "Neuropsychiatric Symptoms Related to Neurodegenerative Disease",
      "Osteoarthritis Pain",
      "Parkinson Disease",
      "Parkinson Disease Psychosis",
      "Parkinson Disease, Parkinson Disease Psychosis, Hallucinations, Delusion",
      "Parkinson's Disease",
      "Parkinson's Disease Psychosis",
      "Rett Syndrome",
      "Schizophrenia",
      "Schizophrenia, Psychosis",
      "Treatment of Depression in Adults With Parkinson's Disease (PD)"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-12T09:03:04.485121",
    "search_query": "ACADIA Pharmaceuticals",
    "url": "https://clinicaltrials.gov/search?term=ACADIA+Pharmaceuticals"
  }
}